- Investing Ideas
- /
- Spanish Pharmaceuticals & Biotech Undervalued based on future growth
Spanish Pharmaceuticals & Biotech Undervalued based on future growth
Results
2
1 new
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
2 companies
Grifols
Market Cap: €6.4b
Operates as a plasma therapeutic company in Spain, the United States, Canada, and internationally.
New
GRF
€10.84
7D
0.8%
1Y
-0.2%
Labiana Health
Market Cap: €31.0m
Develops, manufactures, sells, and markets animal and human health medicine products in Spain, rest of European Union, and internationally.
LAB
€4.40
7D
0%
1Y
109.5%